Dr. Brian Mehling is the founder and Chief Medical Officer of Blue Horizon International, LLC. Dr. Mehling is also a world-renowned orthopedic trauma surgeon whose mainstay of practice is in the greater New York City metropolitan area. Dr. Mehling completed his residency in Orthopedic Surgery at The St. Joseph’s Hospital, Paterson, New Jersey and performed his fellowship in sports medicine at Graduate Hospital, Philadelphia, Pennsylvania. He is an alumnus of The Ohio State University and also holds a Master’s of Science Degree in Biochemistry.
Dr. Mehling first conceived the Blue Horizon International Hospital concept while appraising differences in medical healthcare standards throughout Asia and the Middle East. Dr. Mehling recognized the truly significant need for universally high quality benchmarks in foreign nations and surmised that brining the world’s best physicians to regions abroad would advance the standard of healthcare world-wide. In addition, American Nationals traveling in foreign lands would be able to receive the same quality of healthcare they have grown to expect at home. In association with Blue Horizon International, Blue Horizon’s Stem Cell Therapy Program provides an opportunity for the global community to participate in groundbreaking research while receiving stem cell therapy via state-of-the-art procedures provided in today’s western hospital safety conditions.
Dr. Mehling is also a documentary film producer, recently debuting the film Tiny Tears at the prestigious Cannes Film Festival as well as a philanthropist, supporting many worthy causes dedicated to providing healthcare to children in impoverished areas.
